CUSHING'S SYNDROME
Clinical trials for CUSHING'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CUSHING'S SYNDROME trials appear
Sign up with your email to follow new studies for CUSHING'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New PET scan may pinpoint hidden Cushing's tumors
Diagnosis Recruiting nowThis study tests a new type of PET scan (68Ga-Pentixafor) to see if it can better tell apart the two main types of Cushing's syndrome and find the exact location of the problem. About 160 people with suspected or confirmed Cushing's will get this scan, and results will be compare…
Matched conditions: CUSHING'S SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated May 26, 2026 06:57 UTC
-
New PET tracer could reveal hidden Hormone-Making tumors
Diagnosis Recruiting nowThis study tests whether a new radioactive tracer called [68Ga]Ga-PentixaFor can help doctors identify adrenal tumors that release excess hormones. About 80 adults with adrenal masses and high aldosterone or cortisol levels will receive the tracer and then have a PET scan. The go…
Matched conditions: CUSHING'S SYNDROME
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated May 22, 2026 13:53 UTC
-
New PET scans may unmask hidden tumors in rare hormone disorder
Diagnosis Recruiting nowThis study tests whether newer PET scans (68Ga-DOTATATE and F-DOPA) can better locate the hidden tumors that cause ectopic Cushing syndrome, a rare condition where the body makes too much cortisol. About 80 adults aged 18-90 with this condition will receive these scans along with…
Matched conditions: CUSHING'S SYNDROME
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated May 18, 2026 12:01 UTC